Emery Smith

1.1k total citations
35 papers, 721 citations indexed

About

Emery Smith is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Social Psychology. According to data from OpenAlex, Emery Smith has authored 35 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 4 papers in Social Psychology. Recurrent topics in Emery Smith's work include Receptor Mechanisms and Signaling (16 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (5 papers). Emery Smith is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (5 papers). Emery Smith collaborates with scholars based in United States, United Kingdom and Mexico. Emery Smith's co-authors include Charles Weissmann, Sukhvir P. Mahal, Christopher A. Baker, Louis Scampavia, Christian Julius, Timothy Spicer, Peter Hodder, Jo Ann Janovick, Peter Chase and P. Michael Conn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Emery Smith

33 papers receiving 720 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emery Smith United States 14 537 119 117 117 104 35 721
Patrick G. Needham United States 16 717 1.3× 71 0.6× 312 2.7× 38 0.3× 25 0.2× 29 1.1k
Ewa A. Bienkiewicz United States 13 548 1.0× 64 0.5× 59 0.5× 42 0.4× 28 0.3× 20 722
Baruch Z. Harris United States 10 833 1.6× 153 1.3× 352 3.0× 21 0.2× 67 0.6× 11 1.2k
Daniela Bertinetti Germany 20 816 1.5× 151 1.3× 77 0.7× 23 0.2× 20 0.2× 41 1.0k
Takayuki Fuse Japan 12 664 1.2× 39 0.3× 51 0.4× 110 0.9× 257 2.5× 16 816
Fred C. Westall United States 15 646 1.2× 97 0.8× 47 0.4× 31 0.3× 34 0.3× 39 892
Davy Martin France 11 287 0.5× 29 0.2× 103 0.9× 40 0.3× 75 0.7× 21 551
Heather Sadlish United States 10 573 1.1× 43 0.4× 134 1.1× 21 0.2× 24 0.2× 14 724
Lucille Beaudet Canada 14 492 0.9× 79 0.7× 148 1.3× 41 0.4× 15 0.1× 21 756
Key-Sun Kim South Korea 12 426 0.8× 58 0.5× 65 0.6× 18 0.2× 36 0.3× 17 717

Countries citing papers authored by Emery Smith

Since Specialization
Citations

This map shows the geographic impact of Emery Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emery Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emery Smith more than expected).

Fields of papers citing papers by Emery Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emery Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emery Smith. The network helps show where Emery Smith may publish in the future.

Co-authorship network of co-authors of Emery Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Emery Smith. A scholar is included among the top collaborators of Emery Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emery Smith. Emery Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiaona, Nathan D. Winters, Shubhi Pandey, et al.. (2025). Homeostatic scaling of dynorphin signaling by a non-canonical opioid receptor. Nature Communications. 16(1). 6786–6786. 1 indexed citations
2.
Smith, Emery, Qibin Geng, Yuka Otsuka, et al.. (2025). High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle. SLAS DISCOVERY. 35. 100262–100262.
3.
Smith, Emery, Louise Dickson, Philip Pickford, et al.. (2024). Protocol for kinetic mode potassium channel assays on common plate readers and microscopes. SLAS DISCOVERY. 29(3). 100148–100148.
4.
Smith, Emery, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.. (2023). High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2. SLAS DISCOVERY. 28(3). 95–101. 13 indexed citations
5.
Smith, Emery, Sean Campbell, Pierre Baillargeon, et al.. (2022). High throughput screening for compounds to the orphan nuclear receptor NR2F6. SLAS DISCOVERY. 27(4). 242–248. 5 indexed citations
6.
Smith, Emery, Jo Ann Janovick, Thomas D. Bannister, et al.. (2020). Rescue of mutant gonadotropin-releasing hormone receptor function independent of cognate receptor activity. Scientific Reports. 10(1). 10579–10579. 7 indexed citations
7.
Smith, Emery, Meredith E. Davis-Gardner, Rubén D. Garcia-Ordoñez, et al.. (2020). High-Throughput Screening for Drugs That Inhibit Papain-Like Protease in SARS-CoV-2. SLAS DISCOVERY. 25(10). 1152–1161. 38 indexed citations
8.
Grandjean, Julia M. D., Aparajita Madhavan, Lauren Čech, et al.. (2020). Pharmacologic IRE1/XBP1s activation confers targeted ER proteostasis reprogramming. Nature Chemical Biology. 16(10). 1052–1061. 109 indexed citations
9.
Smith, Emery, Kenneth A. Giuliano, Pierre Baillargeon, et al.. (2017). A Homogeneous Cell-Based Halide-Sensitive Yellow Fluorescence Protein Assay to Identify Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Ion Channel. Assay and Drug Development Technologies. 15(8). 395–406. 7 indexed citations
10.
Wood, Michael R., Meredith J. Noetzel, James C. Tarr, et al.. (2016). Discovery and SAR of a novel series of potent, CNS penetrant M4 PAMs based on a non-enolizable ketone core: Challenges in disposition. Bioorganic & Medicinal Chemistry Letters. 26(17). 4282–4286. 7 indexed citations
11.
Janovick, Jo Ann, Timothy Spicer, Emery Smith, et al.. (2016). Receptor antagonism/agonism can be uncoupled from pharmacoperone activity. Molecular and Cellular Endocrinology. 434. 176–185. 10 indexed citations
12.
Smith, Emery, Peter Chase, Colleen M. Niswender, et al.. (2015). Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4). SLAS DISCOVERY. 20(7). 858–868. 25 indexed citations
13.
Conn, P. Michael, Emery Smith, Timothy Spicer, et al.. (2014). A Phenotypic High Throughput Screening Assay for the Identification of Pharmacoperones for the Gonadotropin Releasing Hormone Receptor. Assay and Drug Development Technologies. 12(4). 238–246. 13 indexed citations
14.
Gentry, Patrick R., Masaya Kokubo, Thomas M. Bridges, et al.. (2014). Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M5‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe. ChemMedChem. 9(8). 1677–1682. 21 indexed citations
15.
Conn, P. Michael, David C. Smithson, Peter Hodder, et al.. (2013). Transitioning pharmacoperones to therapeutic use: In vivo proof-of-principle and design of high throughput screens. Pharmacological Research. 83. 38–51. 23 indexed citations
16.
Gentry, Patrick R., Thomas M. Bridges, Atin Lamsal, et al.. (2013). Discovery of ML326: The first sub-micromolar, selective M5 PAM. Bioorganic & Medicinal Chemistry Letters. 23(10). 2996–3000. 20 indexed citations
17.
18.
Conn, P. Michael, Emery Smith, Peter Hodder, Jo Ann Janovick, & David C. Smithson. (2013). High-Throughput Screen for Pharmacoperones of the Vasopressin Type 2 Receptor. SLAS DISCOVERY. 18(8). 930–937. 25 indexed citations
19.
Browning, Shawn, Christopher A. Baker, Emery Smith, et al.. (2011). Abrogation of Complex Glycosylation by Swainsonine Results in Strain- and Cell-specific Inhibition of Prion Replication. Journal of Biological Chemistry. 286(47). 40962–40973. 28 indexed citations
20.
Mahal, Sukhvir P., et al.. (2008). Assaying Prions in Cell Culture. Methods in molecular biology. 459. 49–68. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick G. Needham Breakdown of academic impact, for papers by Ewa A. Bienkiewicz Breakdown of academic impact, for papers by Baruch Z. Harris Breakdown of academic impact, for papers by Daniela Bertinetti Breakdown of academic impact, for papers by Takayuki Fuse Breakdown of academic impact, for papers by Fred C. Westall Breakdown of academic impact, for papers by Davy Martin Breakdown of academic impact, for papers by Heather Sadlish Breakdown of academic impact, for papers by Lucille Beaudet Breakdown of academic impact, for papers by Key-Sun Kim
Rankless by CCL
2026